The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors.
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly
Research Funding - Bayer; Boehringer Ingelheim
 
Francisco Sanchez-Vega
No Relationships to Disclose
 
Yaelle Tuvy
No Relationships to Disclose
 
Nancy Bouvier
No Relationships to Disclose
 
Jamie Cathleen Riches
No Relationships to Disclose
 
Matthew Margolis
No Relationships to Disclose
 
Brittanie M Millang
No Relationships to Disclose
 
Sasinya N. Scott
No Relationships to Disclose
 
Ritika Kundra
No Relationships to Disclose
 
Pau Castel
No Relationships to Disclose
 
Geoffrey Yuyat Ku
Research Funding - Amgen; Bristol-Myers Squibb; MedImmune; Merck; Millennium
Travel, Accommodations, Expenses - Amgen
 
Jaclyn Frances Hechtman
No Relationships to Disclose
 
David Paul Kelsen
No Relationships to Disclose
 
David H. Ilson
Consulting or Advisory Role - Amgen; Lilly/ImClone; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - Amgen; Bayer; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Genentech/Roche
 
Efsevia Vakiani
No Relationships to Disclose
 
Maurizio Scaltriti
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Novartis; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Barry S. Taylor
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics; Sequenom
 
Nikolaus Schultz
No Relationships to Disclose